Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mohamed Sorror, MD, MSc
Fred Hutch/University of Washington Cancer Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- University of California San Francisco
San Francisco, California, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Northwell Health Cancer Institute
New Hyde Park, New York, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Vanderbilt University
Nashville, Tennessee, United States
- Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
- Fred Hutch/university of Washington Cancer Consortium
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Aug 2019
- Primary completion
- 31 Dec 2025
- Completion
- 31 Dec 2025
- Last update posted
- 12 Jan 2026
- Registered enrollment
- 458
- Registry id
- NCT03870750
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.